文献速递皮肤肿瘤

刮除术与冷冻手术治疗浅表性基底细胞癌:一项前瞻性随机对照试验

Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-05-21

这项单中心非劣效性随机对照试验纳入97例患者的228个非面部浅表性基底细胞癌,比较刮除术与冷冻手术的1年临床清除率和伤口愈合时间。刮除术1年清除率95.7%,冷冻手术100%(P=0.060),非劣效性分析结论不确定;刮除术伤口愈合时间4周短于冷冻手术5周(P<0.0001)。

要点

  • 刮除术与冷冻手术1年临床清除率分别为95.7%和100%(P=0.060)。
  • 非劣效性分析结论不确定。
  • 刮除术伤口愈合时间4周,短于冷冻手术5周(P<0.0001)。

核心结论

  • 两种治疗方法1年临床清除率均高,刮除术缩短了伤口愈合时间。

研究设计与样本

  • 单中心非劣效性临床试验,纳入97例患者的228个直径5-20 mm的非面部浅表性基底细胞癌,随机分配至冷冻手术(一个冻融周期)或刮除术。

主要发现

  • 3-6个月随访时所有治疗区域均未见残留肿瘤。
  • 1年时刮除术临床清除率为95.7%,冷冻手术为100%(P=0.060)。
  • 非劣效性分析结论不确定。
  • 刮除术伤口愈合时间4周,冷冻手术5周(P<0.0001)。
  • 1年时患者总体满意度高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence. Current guidelines for low-risk BCC including superficial BCC (sBCC) recommend several treatment options including destructive treatment methods, such as cryosurgery with or without prior curettage or curettage and electrodesiccation. Curettage only (i.e. without subsequent cryosurgery or electrodesiccation) is a simple and quick destructive treatment method used for many benign skin lesions but has not been sufficiently evaluated for the treatment of sBCCs. OBJECTIVES: The objective was to compare the effectiveness of curettage vs. cryosurgery for sBCCs in terms of overall clinical clearance rates after 1 year as well as wound healing times. METHODS: A single-centre non-inferiority clinical trial was conducted. Non-facial sBCCs with a diameter of 5-20 mm were randomised to either cryosurgery using one freeze-thaw cycle or curettage. At follow-up visits, treatment areas were evaluated regarding the presence of residual tumour after 3-6 months and recurrence after 1 year. Further, wound healing times were assessed. RESULTS: In total, 228 sBCCs in 97 patients were included in the analysis. At 3-6 months, no residual tumours were seen in any of the treated areas. After 1 year, the clinical clearance rates for curettage and cryosurgery were 95.7% and 100%, respectively (P = 0.060). However, the non-inferiority analysis was inconclusive. Wound healing times were shorter for curettage (4 weeks) compared to cryosurgery (5 weeks; P < 0.0001). Overall, patient satisfaction at 1 year was high. CONCLUSIONS: Both treatment methods showed high clinical clearance rates after 1 year, whilst curettage reduced the wound healing time.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Backman EJ, Polesie S, Berglund S, et al. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial. J Eur Acad Dermatol Venereol. 2022. PMID: 35543079. doi:10.1111/jdv.18209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。